| [1] |
2018年第3季度全国艾滋病性病疫情[J]. 中国艾滋病性病,2018,24(11):1075.
|
| [2] |
Lucas S, Nelson AM. HIV and the spectrum of human disease[J]. J Pathol,2015,235(2):229-241.
|
| [3] |
Feng T, Feng X, Jiang C, et al. Sepsis risk factors associated with HIV-1 patients undergoing surgery[J]. Emerg Microbes Infect,2015,4(9):59.
|
| [4] |
赵汝岗, 赵昌松, 李鑫, 等. 人类免疫缺陷病毒阳性青年男性患者四肢闭合骨折内固定术后切口延迟愈合影响因素的研究[J]. 中国矫形外科杂志,2017,25(2):114-118.
|
| [5] |
刘保池, 刘立, 杨昌明, 等. 艾滋病病毒感染者手术后脓毒症的救治[J/CD]. 中华临床医师杂志(电子版),2011,5(9):2742-2744.
|
| [6] |
刘保池, 冯铁男, 李垒, 等. HIV感染患者手术风险评分表的设计和应用[J/CD]. 中华普通外科学文献(电子版),2016,10(3):205-208.
|
| [7] |
Nagasaka S, Yazaki H, Ito H, et al. Effect of CD4+ T-lymphocyte count on hospital outcome of elective general thoracic surgery patients with human immunodeficiency virus[J]. Gen Thorac Cardiovasc Surg,2011,59(11):743-747.
|
| [8] |
杨涤, 赵红心, 郜桂菊, 等. HIV/AIDS手术切口愈合与CD4+ T淋巴细胞计数的关系[J]. 中华流行病学杂志,2014, 35(12): 1333-1336.
|
| [9] |
郭晓峰, 李晶, 李征, 等. HIV/AIDS剖宫产术后切口愈合与CD4+ T淋巴细胞计数关系分析[J]. 罕少疾病杂志,2011,18(2):1-3.
|
| [10] |
Guild GN, Moore TJ, Barnes W, et al. CD4 count is associated with postoperative infection in patients with orthopaedic trauma who are HIV positive[J]. Clin Orthop Relat Res,2012,470(5):1507-1512.
|
| [11] |
刘立, 刘保池. CD4+ T淋巴细胞计数与HIV感染者手术风险评估[J]. 中华全科医学,2011,9(1):7-8.
|
| [12] |
Deneve JL, Shantha JG, Page AJ, et al. CD4 count is predictive of outcome in HIV-positive patients undergoing abdominal operations[J]. Am J Surg,2010,200(6):694-699.
|
| [13] |
Kigera JW, Straetemans M, Vuhaka SK, et al. Is there an increased risk of post-operative surgical site infection after orthopaedic surgery in HIV patients? A systematic review and meta-analysis[J]. PLoS One,2012,7(8):e42254.
|
| [14] |
中华医学会感染病学分会艾滋病学组,中华医学会热带病与寄生虫学分会艾滋病学组. HIV合并结核分枝杆菌感染诊治专家共识[J]. 中华临床感染病杂志,2017,10(2):81-90.
|
| [15] |
Raffi F, Babiker AG, Richert L, et al. Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial[J]. Lancet,2014,384(9958):1942-1951.
|
| [16] |
Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of drug-susceptible tuberculosis[J]. Clin Infect Dis,2016,63(7):e147-e195.
|
| [17] |
中华医学会感染病学分会艾滋病学组,中华医学会热带病与寄生虫学分会艾滋病学组. 中国人类免疫缺陷病毒感染的特殊群体抗病毒治疗专家共识[J]. 中华传染病杂志,2017,35(1):1-4.
|
| [18] |
Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States[J]. Int J Cancer,2008,123(1):187-194.
|
| [19] |
张仁芳, 王江蓉, 江雪艳, 等. 上海地区艾滋病相关性淋巴瘤11例临床分析[J]. 中华内科杂志,2009,48(10):862-863.
|
| [20] |
Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States[J]. J Natl Cancer Inst,2011,103(9):753–762.
|
| [21] |
Winstone TA, Man SFP, Hull M, et al. Epidemic of lung cancer in patients with HIV infection[J]. Chest,2013,143(2):305-314.
|
| [22] |
Morlat P, Roussillon C, Henard S, et al. Causes of death among HIV-infected patients in France in 2010 (national survey)[J]. AIDS,2014,28(8):1181-1191.
|
| [23] |
Park LS, Hernández-Ramírez RU, Silverberg MJ, et al. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS[J]. AIDS,2016,30(2):273-291.
|
| [24] |
Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans[J]. AIDS Educ Prev,2016,21(Supple 3):40-53.
|
| [25] |
Hessol NA, Martínez-Maza O, Levine AM, et al. Lung cancer incidence and survival among HIV-infected and uninfected women and men[J]. AIDS,2015,29(10):1183-1193.
|
| [26] |
Hleyhel M. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009[J]. AIDS,2014,28(14):2109-2118.
|
| [27] |
Levine AM, Seaberg EC, Hessol NA, et al. HIV as a risk factor for lung cancer in women: data from the Women’s Interagency HIV Study[J]. J Clin Oncol,2010,28(9):1514-1519.
|
| [28] |
Shebl FM, Engels EA, Goedert JJ, et al. Pulmonary infections and risk of lung cancer among persons with AIDS[J]. J Acquir Immune Defic Syndr,2010,55(3):375-379.
|
| [29] |
Borges ÁH, Silverberg MJ, Wentworth D, et al. Predicting risk of cancer during HIV infection[J]. AIDS,2013,27(9):1433-1441.
|
| [30] |
Cribbs SK, Lennox J, Caliendo AM, et al. Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages[J]. AIDS Res Hum Retroviruses,2015,31(1):64-70.
|
| [31] |
Marcus JL, Chao C, Leyden WA, et al. Survival among HIV-Infected and HIV-uninfected individuals with common non-AIDS-defining cancers[J]. Cancer Epidemiol Biomarkers Prev,2015,24(8):1167-1173.
|
| [32] |
Suneja G, Shiels MS, Melville SK, et al. Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals[J]. AIDS,2013,27(3):459-468.
|
| [33] |
King JT, Perkal MF, Rosenthal RA, et al. Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators[J]. JAMA Surgery,2015,150(4):343.
|
| [34] |
Hooker CM, Meguid RA, Hulbert A, et al. Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer[J]. Ann Thorac Surg,2012,93(2):405–412.
|
| [35] |
Coghill AE, Shiels MS, Suneja G, et al. Elevated cancer-specific mortality among HIV-infected patients in the United States[J]. J Clin Oncol,2015,33(21):2376-2383.
|
| [36] |
Makinson, A, Tenon JC, Eymard-Duvernay S, et al. Human immunodeficiency virus infection and non-small cell lung vancer: survival and toxicity of antineoplastic chemotherapy in a cohort study[J]. J Thorac Oncol,2011,6(6):1022-1029.
|
| [37] |
王琳, 温子禄, 朱益军, 等. 高效抗逆转录病毒治疗联合化疗对HIV合并肺癌患者骨髓抑制和生存质量评分的影响[J]. 西部医学,2018,30(1):48-51.
|
| [38] |
王琳, 宋言峥. HIV合并肺癌的个体化综合治疗[J]. 中国肺癌杂志,2018,21(4):327-332.
|
| [39] |
刘保池, 张磊, 李垒, 等. 围手术期HIV感染者的抗感染治疗[J/CD]. 中华普通外科学文献(电子版),2012,6(4):3-6.
|
| [40] |
Feng T, Feng X, Jiang C, et al. Sepsis risk factors associated with HIV-1 patients undergoing surgery[J]. Emerg Microbes Infect,2015,4(9):59.
|
| [41] |
Cai J, Xiao J, Zhang Q. Side effects and tolerability of post-exposure prophylaxis with zidovudine, lamivudine, and lopinavir/ritonavir: a comparative study with HIV/AIDS patients[J]. Chin Med J,2014,127(4):2632-2636.
|